ArticleLiver cancer2026

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Masayuki Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.